ESC Premium Access

Welcome and introduction - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.

Topic: Diabetes and the Heart
Sponsored by Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance

Congress Presentation

About the speaker

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
47 presentations
11 followers

5 more presentations in this session

Evidence-based approaches to reducing premature cardiovascular mortality in patients with type 2 diabetes and established cardiovascular disease.

Speaker: Professor D. McGuire (Dallas, US)

Thumbnail

Applying evidence in practice: appropriate use of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in the cardiology clinic.

Speaker: Doctor J. Udell (Toronto, CA) Professor N. Sattar (Glasgow, GB)

Thumbnail

Advancing the standard of care in patients with type 2 diabetes and established cardiovascular disease: how can we improve patient outcomes? .

Speaker: Professor N. Marx (Aachen, DE) Professor D. McGuire (Dallas, US) Doctor J. Udell (Toronto, CA) Professor S. Verma (Toronto, CA) Professor N. Sattar (Glasgow, GB)

Thumbnail

Exploring the effects of SGLT2 inhibition in ongoing trials.

Speaker: Professor S. Verma (Toronto, CA)

Thumbnail

Summary and close - Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice.

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

Access the full session

Reducing cardiovascular mortality in patients with type 2 diabetes: closing the gap between evidence and practice

Speakers: Professor N. Marx, Professor D. McGuire, Doctor J. Udell, Professor N. Sattar, Professor N. Marx...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb